Company / Capital Expenditures
Protagonist Therapeutics, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.6M
FY2025
5-year range
$609.0K / $1.6M
FY2021-FY2025
Trend
+17.3%
vs FY2024
Sector context
#99 of 194
Health Care
What the data says
At $2M, Protagonist Therapeutics, Inc.'s capital expenditures ranks #99 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $347,000 in FY2016 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +27.5%.
Improved from $609,000 to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +26.0%
- 5-Year CAGR
- +27.5%
- 10-Year CAGR
- -
Sector benchmark
#99 of 194 in Health CareTop 51% of 194This company $1.6M Sector average $117.5M
▼
-98.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +27.5%, indicating consistent growth.
- In FY2025, capital expenditures increased 17.3% year-over-year.
- Ranks #99 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6M | +17.3% |
| FY2024 | $1.4M | +122.5% |
| FY2023 | $609.0K | -23.4% |
| FY2022 | $795.0K | -27.8% |
| FY2021 | $1.1M | +133.8% |
| FY2020 | $471.0K | -51.3% |
| FY2019 | $967.0K | +99.0% |
| FY2018 | $486.0K | -27.0% |
| FY2017 | $666.0K | +91.9% |
| FY2016 | $347.0K | -13.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026